PMC Links for Books (Select 4860748) - PMC

Select item 53446441.

A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma

Al B. Benson, III, Zev A. Wainberg, J. Randolph Hecht, Dmitry Vyushkov, Hua Dong, Johanna Bendell, Fred Kudrik

Oncologist. 2017 Mar; 22(3): 241–e15. Published online 2017 Feb 28. doi: 10.1634/theoncologist.2017-0024

PMCID:: PMC5344644

Abstract Article PDF–314K

Select item 48041222.

A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

C. S. Fuchs, S. Azevedo, T. Okusaka, J.-L. Van Laethem, L. R. Lipton, H. Riess, C. Szczylik, M. J. Moore, M. Peeters, G. Bodoky, M. Ikeda, B. Melichar, R. Nemecek, S. Ohkawa, A. Świeboda-Sadlej, S. A. Tjulandin, E. Van Cutsem, R. Loberg, V. Haddad, J. L. Gansert, B. A. Bach, A. Carrato

Ann Oncol. 2015 May; 26(5): 921–927. Published online 2015 Jan 21. doi: 10.1093/annonc/mdv027

PMCID:: PMC4804122

Abstract Article PDF–186K

Select item 45511553.

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

B. H. O'Neil, A. J. Scott, W. W. Ma, S. J. Cohen, D. L. Aisner, A. R. Menter, M. A. Tejani, J. K. Cho, J. Granfortuna, L. Coveler, O. O. Olowokure, J. C. Baranda, M. Cusnir, P. Phillip, J. Boles, R. Nazemzadeh, M. Rarick, D. J. Cohen, J. Radford, L. Fehrenbacher, R. Bajaj, V. Bathini, P. Fanta, J. Berlin, A. J. McRee, R. Maguire, F. Wilhelm, M. Maniar, A. Jimeno, C. L. Gomes, W. A. Messersmith

Ann Oncol. 2015 Sep; 26(9): 1923–1929. Published online 2015 Jun 19. doi: 10.1093/annonc/mdv264

Correction in:: Ann Oncol. 2016 Jun; 27(6): 1180.

Correction in:: Ann Oncol. 2015 Dec; 26(12): 2505.

PMCID:: PMC4551155

Abstract Article PDF–220K

Select item 44462354.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006